Showing results (3931-3940 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|October 26, 2019
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung CancerYuko Tsuchiya-Kawano, Tomonari Sasaki, Hiroyuki Yamaguchi, et al.
The Oncologist|April 17, 2020
Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer DrugsJanice Kim, Abhilasha Nair, Patricia Keegan, et al.
The Oncologist|April 17, 2020
Is "Geriatric" Assessment Just for Older Patients?Gabriel F P Aleixo, Seul Ki Choi, Alyssa J Tan, et al.
The Oncologist|April 17, 2020
Subtype-Guided 18 F-FDG PET/CT in Tailoring Axillary Surgery Among Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: A Feasibility StudySiyu Wu, Yujie Wang, Jianwei Li, et al.
The Oncologist|April 17, 2020
How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian ExperienceGiuseppe Curigliano
The Oncologist|August 19, 2016
Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung CancerGrainne M O'Kane, Catherine Labbé, Mark K Doherty, et al.
The Oncologist|July 25, 2015
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical CenterLaura J Tafe, Ivan P Gorlov, Francine B de Abreu, et al.
The Oncologist|July 25, 2015
Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer PatientsMarvin Delgado-Guay, Jeanette Ferrer, Alyssa G Rieber, et al.
The Oncologist|March 11, 2023
Meta-Analysis of 49 Roche Oncology Trials Comparing Blinded Independent Central Review (BICR) and Local Evaluation to Assess the Value of BICRQinshu Lian, Jill Fredrickson, Kamila Boudier, et al.
The Oncologist|November 18, 2022
Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I TrialsXiao-Li Wei, Yang Zhang, Hong-Yun Zhao, et al.
Pageof 571